's CEO also told The Wall Street Journal the company's coronavirus vaccine candidate could be ready for approval by December. The company's U.S.-listed shares rose 4.75%.
"On days in which there's promise of health solution, or that the economy might actually recover faster than expected, you tend to get all your cyclical stocks ... leading the charge," said one strategist.
369 upwards....
on a Fri. they fall for it every single time. smh,
Since you are busily bending over to every wish of federalreserve wallstreet! Do you realize that this is the 4th complete market pump about the same drug? Zero new news here RemdesivirGate has had more than 200 news articles written about it in the last 90 days.
I pass the usual, cnbc, reuter, bloomberg manipulating the news of the coronavirus, hunting bears for JP morgan, CIti, mongan stannley, black rock, etc., and take it to maximum on Monday with the results of the companies. you will never place them
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: CNBC - 🏆 12. / 72 Lire la suite »